Our draft guideline recommendations for Systemic Treatment of Patients with Ovarian Cancer Experiencing Recurrence are now available for open comment.
Submit feedback to us by January 7: brnw.ch/21wYuR2
Our draft guideline recommendations for Systemic Treatment of Patients with Ovarian Cancer Experiencing Recurrence are now available for open comment.
Submit feedback to us by January 7: brnw.ch/21wYuR2
New evidence-based guideline from @ascocancer.bsky.social on the management of cancer during pregnancy. I had a great conversation with Dr. Alison Loren (@pennmedicine.bsky.social) and Dr. Ann Partridge (@danafarber.bsky.social) on the ASCO Guidelines Podcast guideline.libsyn.com/management-o...
11.12.2025 22:24 — 👍 2 🔁 0 💬 1 📌 0🚀 Stay ahead in cancer care!✨ For the latest @ascocancer.bsky.social #guidelines, check out this must-bookmark webpage: ascopubs.org/guidelines. Plus, don't miss the ASCO Guidelines App & cutting-edge AI assistant! Go-to resources for informed decisions💡 @latinamd.bsky.social @beverlymoy.bsky.social
10.06.2025 01:10 — 👍 8 🔁 3 💬 0 📌 0
🚨New from ASCO: The ASCO Guidelines Assistant, a new generative AI tool developed in collaboration with Google Cloud, more quickly connects ASCO members with timely and trustworthy information. #ASCO25
Learn more: brnw.ch/21wSP18
ACOG is deeply disappointed by HHS’s move to drop COVID-19 vaccine recommendations in pregnancy. The science is clear: COVID-19 remains dangerous in pregnancy and vaccination protects both patients and newborns. The vaccine is safe and protects families. Read our full statement: buff.ly/OGue7sO
27.05.2025 18:34 — 👍 525 🔁 336 💬 13 📌 25
Check out our new rapid recommendation update on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults.
Read full article: brnw.ch/21wSn7M
Our draft guideline recommendations, White Blood Cell Growth Factors, are now available for open comment. Contribute to the advancement of clinical guidelines and enhance your professional impact.
Submit feedback to us by May 15: brnw.ch/21wSljI
On the @ascocancer.bsky.social guidelines podcast, Dr. Nimish Mohile & Dr. Jaishri Blakeley review the evidence from the INDIGO trial that prompted this guideline update, and how to incorporate the use of vorasidenib into clinical practice #ASCOguidelines #oncsky podcasts.apple.com/us/podcast/t...
30.04.2025 13:47 — 👍 1 🔁 0 💬 0 📌 0
Visual Abstract for ASCO-SNO Guideline Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults Rapid Guideline Update Oligodendroglioma, IDH-mutant, 1p19q co-deleted, CNS WHO grade 2 Options Include: - RT + PCV - When toxicity is a concern, RT + temozolimide - For some people with favorable prognostic factors or concerns about toxicity, deferred RT + chemotherapy until radiographic or symptomatic progression - After 1+ surgeries, when RT + chemotherapy has been or can be deferred, vorasidenib may be offered Astrocytoma, IDH-mutant, 1p19q non-codeleted, CNS WHO grade 2 Options include: - RT + adjuvant chemotherapy (temozolimide or PCV) - For some people with favorable prognostic factors or concerns about short- and long-term toxicity, deferred RT + chemotherapy until radiographic or symptomatic progression - After 1+ surgeries, when RT + chemotherapy has been or can be deferred, vorasidenib may be offered Mohile et al J Clin Oncol 2025 asco.org/neurooncology-guidelines
Rapid recommendation update from @ascocancer.bsky.social & @neuroonc.bsky.social on therapy for diffuse astrocytic & oligodendroglial tumors in adults #ASCOguidelines #oncsky #medsky
ascopubs.org/doi/full/10....
Check out our new clinical insights on Fertility Preservation in People With Cancer. This is a companion piece to the updated guideline, published online in the JCO Oncology Practice.
Read more. brnw.ch/21wS8TZ
An expert panel from the American Society of Clinical Oncology, co-chaired by Winship's Mylin Torres, MD, has published updated recommendations for sentinel lymph node biopsy in early-stage breast cancer patients post-surgery. ➡️ brnw.ch/21wS0Eb
16.04.2025 15:22 — 👍 2 🔁 1 💬 0 📌 0Key update in cancer pain management! Check out our latest “Science in Seconds” with Drs. Mellar Davis & Akhila Reddy as they discuss our new guideline “Opioid Conversion in Adults with Cancer.”
14.04.2025 14:31 — 👍 6 🔁 5 💬 0 📌 2
I spoke with Clara Park @ Brigham & Women's & Mylin Torres from @winshipatemory.bsky.social about this latest SLNB guideline update. We discuss the recommendations, importance of shared decision-making and other ongoing & future de-escalation trials #ASCOguidelines podcasts.apple.com/us/podcast/s...
11.04.2025 12:31 — 👍 4 🔁 1 💬 1 📌 0
ASCO Guidelines Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Guideline Update This guideline updates recommendations on the use of SLNB in patients with early-stage breast cancer treated with initial surgery, and includes the following topics: When SLNB can be omitted When ALND is indicated Radiation and systemic treatment decisions after SLNB omission Role of SLNB in special circumstances Park et al J Clin Oncol 2025 asco.org/breast-cancer-guidelines
Our latest guideline update on sentinel lymph node biopsy in patients with early-stage breast cancer treated with initial surgery @ascocancer.bsky.social #ASCOguidelines #MedSky #OncSky
11.04.2025 12:31 — 👍 5 🔁 1 💬 1 📌 0
Want to join us in our efforts? Visit asco.org/actnetwork to contact your Members of Congress about the issues that matter most to you! Advocates are also on the Hill to fix #PriorAuth and protect #CancerResearch funding. #ASCOAdvocacy @ascocancer.bsky.social
08.04.2025 18:23 — 👍 9 🔁 5 💬 0 📌 0
🚨 A must read as more younger people get diagnosed with cancer: Updated @ASCO Guidelines on Fertility Preservation in People With Cancer: | Journal of Clinical Oncology buff.ly/BFpFrw8
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
Protocol for future ASCO guideline on patient-reported outcomes available for comment through Wednesday, April 9 @ascocancer.bsky.social #ASCOguidelines #OncSky #MedSky app.smartsheet.com/b/form/ecf22...
28.03.2025 20:05 — 👍 3 🔁 1 💬 0 📌 1
What health policies do you think we should develop? Tell us using our topic submission form. Submit here ➡️ brnw.ch/21wRxhq
Tell us about:
🔵 the issue
🔵 how the policy aligns with ASCO’s goals
🔵 suggestions for potential policy writers
Attention to reproductive care is essential before cancer therapy begins.” Our latest ‘Science in Seconds’ features Dr. Alison Loren and Dr. Hui-chun Irene Su discussing our updated fertility preservation guideline. Learn more about this guideline: brnw.ch/21wRrAm
19.03.2025 20:54 — 👍 12 🔁 9 💬 0 📌 1
Dr. Irene Su from @ucsdhealthsci.bsky.social & Dr. Alison Loren from @pennmedicine.bsky.social joined me on the #ASCOguidelines podcast to discuss this fertility preservation guideline update, including the new recommendations, current challenges & ongoing research podcasts.apple.com/us/podcast/f...
19.03.2025 20:33 — 👍 1 🔁 0 💬 0 📌 0
ASCO Guidelines Fertility Preservation in People with Cancer Guideline update including recommendations on: Discussing Risks of Infertility Role of Clinicians Fertility Preservation in Males Established or Emerging Methods Include: - Sperm cryopreservation - Testicular sperm extraction Fertility Preservation in Females Established or Emerging Methods Include: - Embryo or oocyte cryopreservation - Ovarian tissue cryopreservation - Ovarian transposition - Conservative gynecologic surgery - In vitro maturation Fertility Preservation in Children Established or Emerging Methods Include: - For those who have begun puberty: semen, oocyte, or ovarian tissue cryopreservation - For pre-pubertal females: ovarian tissue cryopreservation Su et al J Clin Oncol 2025 asco.org/survivorship-guidelines
New guideline update on fertility preservation in people with cancer from @ascocancer.bsky.social
Topics include established, emerging, & investigational fertility preservation methods for adults & children and importance of discussing infertility risks with all patients
ascopubs.org/doi/10.1200/...
Me convincing myself my 401(k) balance isn't down if I don't check it:
15.03.2025 21:10 — 👍 2 🔁 1 💬 0 📌 0Protocol for the @ascocancer.bsky.social guideline update on management of immune-related adverse effects available for open comment through March 19 #ASCOguidelines #irAEs #MedSky #OncSky #SuppOnc app.smartsheet.com/b/form/e3689...
05.03.2025 17:31 — 👍 2 🔁 0 💬 0 📌 0
New published int'l consensus on opioid conversion in adults with cancer using a modified Delphi approach: pre-conversion assessments, strategies for conversion,
and post-conversion assessments link.springer.com/article/10.1... @ascocancer.bsky.social @cancercaremascc.bsky.social @aahpm.bsky.social
Updated @ascocancer.bsky.social living guidelines for NSCLC are out! Participating on the Expert Panel not only gives me hope to see so many new treatments, it also reminds me how challenging it must be for clinicians to keep up.
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
🔥🔥Off the press Updated @ASCO Living Guidelines on Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations, Version 2024.3
▶️ Discussion of 2nd line options
▶️ Update on T-Dxd for HER2 IHC3+ lungcancer
▶️ No consensus on use of TTF, Dato-DXd
👉🏽 ascopubs.org/doi/10.1200/...
We’ve issued a guideline update on therapy for stage IV #NSCLC without driver alterations. #lungcancer #LCSM
Read more: brnw.ch/21wR0fb
Just issued: new living guideline update on therapy for stage IV #NSCLC with driver alterations. Read more: brnw.ch/21wR0fn
#LungCancer #LCSM
Dr. Jyoti Patel from Northwestern University discusses the updates to the stage IV with driver alterations guideline, including the complex implementation of first- and second-line therapeutic recommendations and ongoing developments in the field #lungcancer #LCSM
podcasts.apple.com/us/podcast/t...
